Elorali and Orforgli Are the Next Molecules in the Weight Loss Pipeline
*This article is community-sourced educational material, not medical advice. The compounds tracked here as elorali and orforgli are eloralintide and
Tirzepatide and the Dual Incretin Mechanism
Tirzepatide is an approved molecule that carries both incretin hormones in a single peptide, and the trial record that followed
The Alcohol Mirror That Explains Food Noise
Drawn from public community discussion and labeled as community-sourced observation throughout, this is what people who use GLP-1 receptor agonists
Semaglutide: How the First Oral GLP-1 Changed Metabolic Medicine
The story of semaglutide is the story of a peptide that crossed the last barrier in drug delivery, and the
Why the Scanner Says 8% Body Fat and the Mirror Disagrees
The DEXA scan reports a body-fat number with a confidence the mirror refuses to confirm, and after a hundred-pound loss
What the Evidence Says About Peptide Stacks for Weight Loss
The marketed peptide stacks for weight loss all run ahead of the evidence, so this article maps each compound to
The 2mg GHK-Cu Dose Was Pulled From a Hat
Every GHK-Cu dosing chart repeats the same number, 2mg, and the number looks like a protocol precisely because it gets
What Happens When You Stop GLP-1 Therapy
The withdrawal trials and real-world cohorts now quantify what comes back when GLP-1 therapy stops, and the honest answer mixes
The FDA-Approved Secretagogue the Community Underuses
Most of the growth hormone peptide catalog runs on folklore, and then there is tesamorelin, a compound that cleared FDA
GHK-Cu is the iceberg peptide
GHK-Cu was discovered in 1973 by Dr. Loren Pickart, who found that a tripeptide in human plasma, glycine-histidine-lysine bound to